Association of 340B entity eligibility with changes in hospital financial performance
Neal Masia, Jonathan D Campbell, Yevgeniy Feyman, Kenneth Finegold · 2026
Read Association of 340B entity eligibility with changes in hospital financial performance by Neal Masia, Jonathan D Campbell, Yevgeniy Feyman, Kenneth Finegold (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13268763.txt.
Description
Neal Masia and colleagues present a 2026 study of hospital finances under the US 340B drug discount program. The program forces drug makers to discount medicines for hospitals serving many vulnerable patients. Lawmakers now worry hospitals pocket the savings. Using 2023 Medicare cost reports and program records, the team compared hospitals eligible for 340B with those not eligible, excluding small critical access hospitals.
The average 340B hospital held about half again more total assets than non-340B hospitals. More 340B sites under one hospital tracked with faster real asset growth. Eligible hospitals also spent more on administrative salaries. The authors conclude 340B hospitals show consistently strong finances, outpacing ineligible peers. They offer the findings as evidence for the ongoing debate over how hospitals use program proceeds.
Catalog record
| CREATOR | Neal Masia, Jonathan D Campbell, Yevgeniy Feyman, Kenneth Finegold |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 19727 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |